Neogen® to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Neogen Corporation announced its participation in the 41st Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Neogen Corporation announced its participation in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on January 11, 2023. Neogen's President and CEO, John Adent, will present at 8:15 a.m. Pacific Time. Interested parties can access the presentation materials and webcast through the Neogen Investor Relations website.
Neogen specializes in food and animal safety solutions, offering diagnostic test kits and genomic products.
Details
News Market Reaction – NEOG
The recorded move for NEOG in the trading session of this news was +4.48%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LANSING, Mich., Dec. 29, 2022 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 11, 2023.
John Adent, Neogen's President and Chief Executive Officer, will present at 8:15 a.m. Pacific Time.
To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.
Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.
CONTACT: | Bill Waelke, Investor Relations |
View original content:https://www.prnewswire.com/news-releases/neogen-to-participate-in-the-41st-annual-jp-morgan-healthcare-conference-301710994.html
SOURCE Neogen Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.